tadalafil has been researched along with Nocturia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ashida, S; Fukata, S; Fukuhara, H; Inoue, K; Karashima, T; Komatsu, F; Kuno, T; Kuroiwa, H; Saito, M; Sawada, K; Tamura, K; Watanabe, H; Yasuda, M | 1 |
| Eto, M; Mimata, H; Miyazato, M; Nishii, H; Oshiro, T; Saito, S; Sumino, Y; Takahashi, R; Yoshida, M | 1 |
| Cox, D; Mamoulakis, C; Oelke, M; Ruff, D; Viktrup, L; Weiss, JP | 1 |
1 trial(s) available for tadalafil and Nocturia
| Article | Year |
|---|---|
Effects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies.
Topics: Carbolines; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nocturia; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil | 2014 |
2 other study(ies) available for tadalafil and Nocturia
| Article | Year |
|---|---|
Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting.
Topics: Aged; Humans; Lower Urinary Tract Symptoms; Male; Nocturia; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Treatment Outcome | 2022 |
Tadalafil Improves Nocturia and Nocturia-Related Quality of Life in Patients with Benign Prostatic Hyperplasia (KYU-PRO Study).
Topics: Aged; Aged, 80 and over; Diagnostic Self Evaluation; Humans; Male; Nocturia; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Tadalafil; Treatment Outcome | 2020 |